Table 1.
Seroconversion to norovirus (NoV) and to rotavirus (RV) at different age.
| Donor | 12 mo | 2–3 y | 4 y | |||
|---|---|---|---|---|---|---|
| NoV GI.3/GII.4 | RV | NoV GI.3/GII.4 | RV | NoV GI.3/GII.4 | RV | |
| 1a | −/+ | — | +/− | + | +/− | + |
| 2 | −/+ | + | +/+ | — | −/− | — |
| 3b | −/− | — | +/+ | + | +/− | — |
| 4 | −/− | — | −/+ | + | −/+ | + |
| 5a | −/− | — | +/+ | — | −/− | — |
| 6 | −/− | + | −/− | + | −/+ | — |
| 7 | −/− | — | −/− | — | −/+ | — |
| 8 | −/− | — | −/− | + | +/− | — |
| 9 | −/− | + | −/+ | — | −/− | + |
| 10 | −/− | + | −/+ | — | −/+ | — |
aReceived RV vaccine (3 doses) before 6 months of age.
bReceived RV vaccine (1 dose) before 3 months of age.
−, no seroconversion (<four-fold increase in IgG end-point titer of sequential serum samples). +, seroconversion (≥four-fold increase in IgG end-point titer of sequential serum samples).